BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 38296469)

  • 1. Applicable Machine Learning Model for Predicting Contrast-induced Nephropathy Based on Pre-catheterization Variables.
    Choi H; Choi B; Park I
    Intern Med; 2024 Feb; ():. PubMed ID: 38296469
    [No Abstract]   [Full Text] [Related]  

  • 2. Prediction of the development of contrast‑induced nephropathy following percutaneous coronary artery intervention by machine learning.
    Ma X; Mo C; Li Y; Chen X; Gui C
    Acta Cardiol; 2023 Oct; 78(8):912-921. PubMed ID: 37052397
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictive modeling for acute kidney injury after percutaneous coronary intervention in patients with acute coronary syndrome: a machine learning approach.
    Behnoush AH; Shariatnia MM; Khalaji A; Asadi M; Yaghoobi A; Rezaee M; Soleimani H; Sheikhy A; Aein A; Yadangi S; Jenab Y; Masoudkabir F; Mehrani M; Iskander M; Hosseini K
    Eur J Med Res; 2024 Jan; 29(1):76. PubMed ID: 38268045
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Folic Acid Attenuates Contrast-Induced Nephropathy in Patients With Hyperhomocysteinemia Undergoing Coronary Catheterization: A Randomized Controlled Trial.
    Peng L; Shui X; Tan F; Li Z; Ling Y; Wu B; Chen L; Li S; Peng H
    Front Cardiovasc Med; 2021; 8():707328. PubMed ID: 34660712
    [No Abstract]   [Full Text] [Related]  

  • 5. Contrast induced nephropathy in patients with pre-existing renal impairment undergoing coronary angiogram and percutaneous transluminal coronary angioplasty.
    Subedi B; Siddique MA; Zaman SM; Hasan MI; Arzu J; Awal A; Fatema K
    Mymensingh Med J; 2011 Apr; 20(2):270-4. PubMed ID: 21522099
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radial access protects from contrast media induced nephropathy after cardiac catheterization procedures.
    Feldkamp T; Luedemann M; Spehlmann ME; Freitag-Wolf S; Gaensbacher J; Schulte K; Bajrovic A; Hinzmann D; Hippe HJ; Kunzendorf U; Frey N; Luedde M
    Clin Res Cardiol; 2018 Feb; 107(2):148-157. PubMed ID: 28939956
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel risk assessment model of contrast-induced nephropathy after percutaneous coronary intervention in patients with diabetes.
    Yao ZF; Shen H; Tang MN; Yan Y; Ge JB
    Basic Clin Pharmacol Toxicol; 2021 Feb; 128(2):305-314. PubMed ID: 32991776
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of the risk factors for contrast-induced nephropathy in over-aged patients receiving coronary intervention.
    Pan HC; Wu XH; Wan QL; Liu And BH; Wu XS
    Exp Biol Med (Maywood); 2018 Aug; 243(12):970-975. PubMed ID: 30299175
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New perspectives on contrast-induced nephropathy during coronary interventions.
    Alhudairy M; Abdelazeem M; Aoun J
    Future Cardiol; 2022 Jul; 18(7):519-522. PubMed ID: 35695434
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of nicorandil treatment for prevention of contrast-induced nephropathy in high-risk patients undergoing cardiac catheterization: A prospective randomized controlled trial.
    Iranirad L; Hejazi SF; Sadeghi MS; Jang SA
    Cardiol J; 2017; 24(5):502-507. PubMed ID: 28281738
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevention of Contrast and Radiation Injury During Coronary Angiography and Percutaneous Coronary Intervention.
    Afshar AE; Parikh PB
    Curr Treat Options Cardiovasc Med; 2018 Mar; 20(4):32. PubMed ID: 29569013
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute Kidney Injury Risk Prediction in Patients Undergoing Coronary Angiography in a National Veterans Health Administration Cohort With External Validation.
    Brown JR; MacKenzie TA; Maddox TM; Fly J; Tsai TT; Plomondon ME; Nielson CD; Siew ED; Resnic FS; Baker CR; Rumsfeld JS; Matheny ME
    J Am Heart Assoc; 2015 Dec; 4(12):. PubMed ID: 26656858
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The efficacy of N-acetylcysteine plus sodium bicarbonate in the prevention of contrast-induced nephropathy after cardiac catheterization and percutaneous coronary intervention: A meta-analysis of randomized controlled trials.
    Zhao SJ; Zhong ZS; Qi GX; Tian W
    Int J Cardiol; 2016 Oct; 221():251-9. PubMed ID: 27404685
    [TBL] [Abstract][Full Text] [Related]  

  • 14. How to Construct an Optimal Risk Model for Contrast-induced Nephropathy.
    Kataoka N; Imamura T
    Intern Med; 2024 Feb; ():. PubMed ID: 38296471
    [No Abstract]   [Full Text] [Related]  

  • 15. Correlation of the Neutrophil-to-Lymphocyte Ratio (NLR) and Platelet-to-Lymphocyte Ratio (PLR) with Contrast-Induced Nephropathy in Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Interventions.
    Butt K; D'Souza J; Yuan C; Jayakumaran J; Nguyen M; Butt HI; Abusaada K
    Cureus; 2020 Dec; 12(12):e11879. PubMed ID: 33415032
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early Small Creatinine Shift Predicts Contrast-Induced Acute Kidney Injury and Persistent Renal Damage after Percutaneous Coronary Procedures.
    Benini A; Scarsini R; Pesarini G; Pighi M; Ferrero V; Gambaro A; Piccoli A; Marin F; Inciardi RM; Gambaro G; Lupo A; Ribichini F
    Cardiovasc Revasc Med; 2020 Mar; 21(3):305-311. PubMed ID: 31204242
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Frequency and risk factors of contrast-induced nephropathy after cardiac catheterization in type II diabetic patients: a study among Egyptian patients.
    Sany D; Refaat H; Elshahawy Y; Mohab A; Ezzat H
    Ren Fail; 2014 Mar; 36(2):191-7. PubMed ID: 24138570
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Evolution of contrast nephropathy in patients with chronic kidney disease undergoing a percutaneous coronary intervention].
    López-López B; Pérez-López MJ; García-Rincón A; Vázquez-Vega B
    Rev Med Inst Mex Seguro Soc; 2015; 53(4):484-8. PubMed ID: 26177437
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of thyroid functions on contrast-induced nephropathy in patients undergoing coronary angiography and percutaneous coronary intervention.
    Gurdogan M; Ari H
    J Pak Med Assoc; 2019 Oct; 69(10):1453-1458. PubMed ID: 31622296
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel risk score model for prediction of contrast-induced nephropathy after emergent percutaneous coronary intervention.
    Lin KY; Zheng WP; Bei WJ; Chen SQ; Islam SM; Liu Y; Xue L; Tan N; Chen JY
    Int J Cardiol; 2017 Mar; 230():402-412. PubMed ID: 28043662
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.